Bibliography
Found 11 results
Filters: Keyword is Central Nervous System [Clear All Filters]
Biotypes of Central Nervous System Complications in People With Human Immunodeficiency Virus: Virology, Immunology, and Neuropathology. J Infect Dis. 2023 ;227(Suppl 1):S3-S15.
. Cerebrospinal fluid extracellular vesicles and neurofilament light protein as biomarkers of central nervous system injury in HIV-infected patients on antiretroviral therapy. AIDS. 2019 ;33(4):615-625.
. Comparative study of methods for detecting sequence compartmentalization in human immunodeficiency virus type 1. Journal of Virology [Internet]. 2007 ;81:6643-51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17428864
. Elevated cerebrospinal fluid Galectin-9 is associated with central nervous system immune activation and poor cognitive performance in older HIV-infected individuals. J Neurovirol. 2019 ;25(2):150-161.
Eradication of HIV from Tissue Reservoirs: Challenges for the Cure. AIDS Res Hum Retroviruses. 2018 ;34(1):3-8.
. Heme oxygenase-1 deficiency accompanies neuropathogenesis of HIV-associated neurocognitive disorders. J Clin Invest. 2014 ;124(10):4459-72.
. Human immunodeficiency virus infection inhibits granulocyte-macrophage colony-stimulating factor-induced microglial proliferation. Journal of Neurovirology [Internet]. 2007 ;13:536-48. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18097885
. Polyamines: Predictive Biomarker for HIV-Associated Neurocognitive Disorders. Journal of AIDS & Clinical Research. 2014 ;5(6).
. Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol. 2008 ;65(1):65-70.
When do models of NeuroAIDS faithfully imitate "the real thing"?. J Neurovirol. 2018 ;24(2):146-155.
.